But she also emphasized that GLP-1 medications such as Mounjaro and Ozempic are not the only options when it comes to weight loss or diabetes, and significantly more affordable FDA-approved ...
(The Hill) – Federal regulators shook up the booming weight loss drug marketplace ... Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions ...